142 related articles for article (PubMed ID: 22795114)
1. Stage III malignant mixed Müllerian tumor of the fallopian tube: a case of 5-year survival after optimal debulking and adjuvant chemotherapy with paclitaxel plus carboplatin.
Tsai CP; Ho ES; Ke YM; Hsu ST; Wang RC; Lu CH
Taiwan J Obstet Gynecol; 2012 Jun; 51(2):294-6. PubMed ID: 22795114
[No Abstract] [Full Text] [Related]
2. Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.
Kawaguchi W; Itamochi H; Kigawa J; Kanamori Y; Oishi T; Shimada M; Sato S; Sato S; Terakawa N
Int J Clin Oncol; 2008 Oct; 13(5):461-3. PubMed ID: 18946759
[TBL] [Abstract][Full Text] [Related]
3. Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
Matulonis UA; Krag KJ; Krasner CN; Atkinson T; Horowitz NS; Lee H; Penson RT
Gynecol Oncol; 2009 Feb; 112(2):394-9. PubMed ID: 19058838
[TBL] [Abstract][Full Text] [Related]
4. Malignant mixed müllerian tumor of the fallopian tube.
Zorlu CG; Cobanoglu O; Kuşçu E; Aribas D
Acta Obstet Gynecol Scand; 1994 Apr; 73(4):352-4. PubMed ID: 8160547
[TBL] [Abstract][Full Text] [Related]
5. Primary malignant mixed Müllerian tumor of the fallopian tube after subtotal hysterectomy: a case report and literature review.
Ji J; Zuo P; Li L; Wang Y
Arch Gynecol Obstet; 2015 May; 291(5):1187-90. PubMed ID: 25588328
[No Abstract] [Full Text] [Related]
6. Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
Onda T; Kobayashi H; Nakanishi T; Hatae M; Iwasaka T; Konishi I; Shibata T; Fukuda H; Kamura T; Yoshikawa H
Gynecol Oncol; 2009 Apr; 113(1):57-62. PubMed ID: 19181369
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.
Cass I; Resnik E; Chambers JT; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE
Gynecol Oncol; 1996 Jun; 61(3):309-14. PubMed ID: 8641607
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.
Gemignani ML; Hensley ML; Cohen R; Venkatraman E; Saigo PE; Barakat RR
Gynecol Oncol; 2001 Jan; 80(1):16-20. PubMed ID: 11136563
[TBL] [Abstract][Full Text] [Related]
9. Stage I primary malignant mixed müllerian tumor of the fallopian tube. Report of a case with five-year survival after minimal surgery without adjuvant treatment.
Ebert AD; Perez-Canto A; Schaller G; Entezami M; Hopp HS; Weitzel HK
J Reprod Med; 1998 Jul; 43(7):598-600. PubMed ID: 9693413
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for malignant mixed Müllerian tumors of the ovary.
Sit AS; Price FV; Kelley JL; Comerci JT; Kunschner AJ; Kanbour-Shakir A; Edwards RP
Gynecol Oncol; 2000 Nov; 79(2):196-200. PubMed ID: 11063643
[TBL] [Abstract][Full Text] [Related]
11. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.
Onda T; Matsumoto K; Shibata T; Sato A; Fukuda H; Konishi I; Kamura T; Yoshikawa H;
Jpn J Clin Oncol; 2008 Jan; 38(1):74-7. PubMed ID: 18258715
[TBL] [Abstract][Full Text] [Related]
12. Malignant mixed Müllerian tumor of the fallopian tube: a case report.
Watanabe T; Sugino T; Furukawa S; Soeda S; Nishiyama H; Fujimori K
Eur J Gynaecol Oncol; 2012; 33(2):223-6. PubMed ID: 22611970
[TBL] [Abstract][Full Text] [Related]
13. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
[TBL] [Abstract][Full Text] [Related]
14. Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma.
Gagner JP; Mittal K
Gynecol Oncol; 2005 Apr; 97(1):219-22. PubMed ID: 15790462
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.
Hoskins PJ; Le N; Ellard S; Lee U; Martin LA; Swenerton KD; Tinker AV;
Gynecol Oncol; 2008 Jan; 108(1):58-62. PubMed ID: 17935761
[TBL] [Abstract][Full Text] [Related]
16. Recurrent metastatic fallopian tube carcinoma in pregnancy.
Adolph A; Le T; Khan K; Biem S
Gynecol Oncol; 2001 Apr; 81(1):110-2. PubMed ID: 11277660
[TBL] [Abstract][Full Text] [Related]
17. Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature.
Duman BB; Kara IO; Günaldi M; Ercolak V
Arch Gynecol Obstet; 2011 Jun; 283(6):1363-8. PubMed ID: 21298439
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass.
Scholz HS; Lax S; Tamussino KF; Benedicic C; Petru E
Anticancer Res; 2000; 20(6C):4801-2. PubMed ID: 11205221
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and carboplatin therapy in stage I fallopian tube carcinoma.
Gungor T; Altundag OB; Ustunyurt E; Mollamahmutoglu L
Int J Gynaecol Obstet; 2006 Nov; 95(2):163-4. PubMed ID: 16828094
[No Abstract] [Full Text] [Related]
20. Current management of fallopian tube carcinoma.
Gadducci A
Curr Opin Obstet Gynecol; 2002 Feb; 14(1):27-32. PubMed ID: 11801873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
